Study comparing standard dose and high-dose imatinib mesylate in patients with chronic phase Ph+ CML.
Phase of Trial: Phase IV
Latest Information Update: 28 Feb 2017
At a glance
- Drugs Imatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 30 Apr 2012 Planned end date (Jun 2007) added as reported by ClinicalTrials.gov.
- 23 Oct 2005 New trial record.